Trial intelligence / Profile preview

Propranolol for Memory Reconsolidation in Smoking Cessation

NCT00916721Phase 3Completed

Sponsor
Massachusetts General Hospital
Start
Apr 2008
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of propranolol in nicotine dependence, sponsored by Massachusetts General Hospital. Started Apr 2008; status: completed.

02

Drugs

propranolol
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT00916721.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00916721.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call